These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Parvovirus vectors: use and optimisation in cancer gene therapy. Blechacz B; Russell SJ Expert Rev Mol Med; 2004 Jul; 6(16):1-24. PubMed ID: 15387896 [TBL] [Abstract][Full Text] [Related]
25. Biophysical targeting of adenovirus vectors for gene therapy. Silman NJ; Fooks AR Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755 [TBL] [Abstract][Full Text] [Related]
26. Development of PEGylated adenovirus vector with targeting ligand. Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316 [TBL] [Abstract][Full Text] [Related]
27. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria. Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332 [TBL] [Abstract][Full Text] [Related]
28. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Douglas KL Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953 [TBL] [Abstract][Full Text] [Related]
29. Design of retroviral vectors and helper cells for gene therapy. Hu WS; Pathak VK Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508 [TBL] [Abstract][Full Text] [Related]
30. Targeted gene delivery to the lung. Aneja MK; Geiger JP; Himmel A; Rudolph C Expert Opin Drug Deliv; 2009 Jun; 6(6):567-83. PubMed ID: 19450167 [TBL] [Abstract][Full Text] [Related]
31. What role can chemistry play in cationic liposome-based gene therapy research today? Kostarelos K; Miller AD Adv Genet; 2005; 53():71-118. PubMed ID: 16240991 [TBL] [Abstract][Full Text] [Related]
33. Targeting of liposomes to hepatocytes. Ghosh PC; Bachhawat BK Targeted Diagn Ther; 1991; 4():87-103. PubMed ID: 1724610 [TBL] [Abstract][Full Text] [Related]
34. Impact of liposomes as delivery systems in veterinary medicine. Sallovitz JM; Zonco Menghini MI; Lanusse CE Vet Res; 1998; 29(5):409-30. PubMed ID: 9779555 [TBL] [Abstract][Full Text] [Related]
35. [The liver-cell specific drug delivery system]. Goto M Nihon Rinsho; 1994 Aug; 52(8):2214-24. PubMed ID: 7933613 [TBL] [Abstract][Full Text] [Related]
36. [Gene therapy: nucleic acids as drugs. Action mechanisms and delivery into the cell]. Cavagnari BM Arch Argent Pediatr; 2011 Jun; 109(3):237-44. PubMed ID: 21660389 [TBL] [Abstract][Full Text] [Related]
37. Drug targeting to the diseased liver. Poelstra K; Prakash J; Beljaars L J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583 [TBL] [Abstract][Full Text] [Related]
38. Targeting of drugs to the liver. Meijer DK; Molema G Semin Liver Dis; 1995 Aug; 15(3):202-56. PubMed ID: 7491504 [No Abstract] [Full Text] [Related]
39. [Liposomes as non-viral carriers for genetic drugs]. Meissner JM; Toporkiewicz M; Matusewicz L; Machnicka B Postepy Hig Med Dosw (Online); 2016 Mar; 70():200-9. PubMed ID: 27117095 [TBL] [Abstract][Full Text] [Related]
40. Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology. Omidi Y; Barar J; Akhtar S Curr Drug Deliv; 2005 Oct; 2(4):429-41. PubMed ID: 16305446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]